XIIlab씨이랩
189330 · KOSDAQ · ₩189330 · 씨이랩
₩8,070▼ ₩830 (9.33%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩2B | ₩1.1B | ₩4.9B | ₩3.8B | ₩716M | ₩784M | ₩3.9B | ₩2.6B |
| Cost of sales | ₩1.7B | ₩896M | ₩3.5B | ₩3.3B | ₩574M | ₩505M | ₩3.1B | ₩2.2B |
| Gross profit | ₩333M | ₩217M | ₩1.5B | ₩558M | ₩143M | ₩279M | ₩800M | ₩424M |
| Operating income | −₩2.7B | −₩1.9B | −₩248M | −₩662M | −₩1.2B | −₩1.1B | −₩282M | −₩1.1B |
| Net income | −₩808M | −₩1.8B | −₩2.5B | ₩640M | −₩394M | −₩841M | −₩251M | −₩1.1B |
| Net income to shareholders | −₩2.6B | −₩1.8B | −₩447M | −₩595M | −₩1.2B | −₩841M | −₩251M | −₩1.1B |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩24B | ₩26B | ₩29B | ₩29B | ₩10B | ₩11B | ₩13B | ₩14B |
| Current assets | ₩22B | ₩24B | ₩28B | ₩27B | ₩7.3B | ₩8.1B | ₩10B | ₩10B |
| Cash and equivalents | ₩2.5B | ₩1.8B | ₩8.1B | ₩8.1B | ₩3.7B | ₩4.9B | ₩3.2B | ₩2B |
| Total liabilities | ₩2.8B | ₩2.5B | ₩4.3B | ₩3.4B | ₩2.7B | ₩2.4B | ₩3.8B | ₩3.9B |
| Current liabilities | ₩2.3B | ₩1.4B | ₩3.3B | ₩2.5B | ₩1.7B | ₩1.3B | ₩2.6B | ₩2.5B |
| Total equity | ₩21B | ₩23B | ₩25B | ₩26B | ₩7.5B | ₩8.8B | ₩9.6B | ₩9.9B |
| Shareholders' equity | ₩21B | ₩23B | ₩25B | ₩26B | ₩7.5B | ₩8.8B | ₩9.6B | ₩9.9B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −₩2.1B | −₩3.5B | ₩2B | −₩147M | −₩1.4B | −₩1.1B | ₩409M | −₩1.2B |
| Capital spending | ₩133M | ₩134M | ₩619M | ₩22M | ₩2.9M | ₩11M | ₩0 | ₩264M |
| Free cash flow | −₩2.2B | −₩3.6B | ₩1.3B | −₩169M | −₩1.4B | −₩1.1B | ₩409M | −₩1.4B |
Consolidated where available. Amounts in won.
Also known as: XIIlab / 씨이랩 / 189330 / KRX:189330
Source: KRX statistical information